Yosdi Arcos

Yosdi arcos

bookmark on deepenrich
location of Yosdi ArcosMexico City Metropolitan Area
Phone number of Yosdi Arcos+91 xxxx xxxxx
Followers of Yosdi Arcos1000 followers
  • Timeline

    Jan 2004 - Jan 2005

    Intern Marketing

    Telmex
    Jan 2005 - Jan 2006

    Sales Equipment Assistant

    Dell EMC
    Jan 2007 - Jan 2008

    Coordinadora de Soporte Tecnico

    Varian, Inc.
    Jan 2008 - Jan 2011

    Market Research Specialist

    Boehringer Ingelheim
    Ciudad de México y alrededores, México
    Jan 2012 - Jan 2018

    Product Manager Diabetes Jardianz

    Boehringer Ingelheim
    Ciudad de México y alrededores, México
    Sept 2018 - Mar 2020

    Product Manager Gastro

    Takeda
    Current Company
    Mar 2020 - now

    Business Unit Leader

    Amgen
    Ciudad de México, México
  • About me

    Business Unit Leader

  • Education

    • Tecnológico de monterrey

      2010 - 2011
      Diploma marketing farmacéutico
    • Tecnológico de monterrey

      2001 - 2006
      Bachelor's degree business administration (bba)
    • Tecnológico de monterrey

      2011 - 2012
      Diploma innovate marketing
    • Tecnológico de monterrey

      2017 - 2018
      Diplomado marketing digital
    • Wharton executive education

      2023 - 2023
      Marketing diploma marketing/marketing management, general
  • Experience

    • Telmex

      Jan 2004 - Jan 2005
      Intern marketing
    • Dell emc

      Jan 2005 - Jan 2006
      Sales equipment assistant
    • Varian, inc.

      Jan 2007 - Jan 2008
      Coordinadora de soporte tecnico
    • Boehringer ingelheim

      Jan 2008 - Jan 2011

      - Designed and execution of a new incentive plan; Tangible, Easier to understand, Challenging but Reachable, Predictable and Motivating, which brought BI better productivity and improvement in other commercial indicators. - Development and Automation of 80% of reports in the area, by using Macros in Excel, decreasing delivery time by 70%, and also changed from being a reporting area to an analytical and supporting marketing area.- Implementation of multi-variable analysis and reports using (INTE, PMM, CSD, Close UP and ATV) in order to have an understanding of sub-segments by pathologies: Cardiovascular, Nervous System, Laxative, Analgesic, Respiratory and Oncological. Show less

      • Market Research Specialist

        Jan 2008 - Jan 2011
      • Sales Representative

        Jan 2008 - Jan 2008
    • Boehringer ingelheim

      Jan 2012 - Jan 2018

      Jardianz Franchice, iSGLT2 product positioning, CV Indication launch, Comarketing with Lilly.- Obtained Jardianz Family leadership, one year after Cardiovascular Indication launch, considering, it was the 3rd product launched in the market within its therapeutical class, all of it through developing innovative launch and tracking strategies, of internal and external campaign. - Positioned the product as a leader in the market in prescriptions, mainly with Cardiology, endocrinology and Internist specialties, through developing marketing strategies, were the cardiovascular benefit that it offers was highlighted.- Consolidated leadership of Jardianz family in values with positive growth and with double digit: Jardianz Duo 170% Growth 2017 vs 2018, Jardianz 41% Growth 2017 vs 2018.- Designed, Launched and tracking of "PRODIANZ" web page, with the driver of increasing the number of Jardianz family prescribers, increasing product knowledge with non-visited PCP´s, through Facebook and LinkedIn strategies and also updating SEO to increase traffic. - Positioned Jardianz Franchise as a Key Driver of the iSGLT2 market, growing double digits and always growing above competitors and market, surpassing budget in 2016 and 2017, 2017 growth of 90% vs. the previous year and 103% vs. budget.- Achieved Jardianz Family leadership a few months after developing an internal campaign focused on cardiovascular indication benefit. - Launched Jardianz and the new indication in Central America, due to a tracking and management of Jardianz Launch in Central America, using Mexico´s strategies in Salvador, Guatemala, Costa Rica, Honduras and finally in Panama. Show less - Developed Launch strategies that positioned Micardis Duo as the best launch product in its therapeutic area, surpassing expected forecast and growing double digit. - Delivered extraordinary revenues of more than $1,300 Mio pesos and an amazing performance during 3 consecutive years by developing positioning and selling strategies. - Delivered an extraordinary Micardis Franchise performance during three consecutive years with results substantially above budget and reflecting double digit growth.- Successfully developed and implemented Micardis Plus´s LoE plan to mitigate sales erosion. Expanding my experience in launching generics of Micaridis franchise in main channels like: Wal-Mart, Farmacias del Ahorro and Farmacias Similares.o Achieved for BI, an ASPID award for best communication and positioning strategy in the “Los Corazones son Unicos y tus pacientes tambien” campaign, maintaining the franchises double digit growth during 2014. o Obtained a close relationship with Cardiology societies like: ANCAM, Mexican Society of Cardiology, and CADECI, reaching important negotiations for our participation in congresses with a superior impact and the same resources. - Pioneer in the launch of digital campaigns for the Micardis Family, increasing brand awareness of those none visited physicians, through an APP and a Web page. Show less

      • Product Manager Diabetes Jardianz

        Jan 2016 - Jan 2018
      • Product Manager Cardiovascular Micardis

        Jan 2012 - Jan 2016
      • Brand associate

        Jan 2012 - Jan 2013
    • Takeda

      Sept 2018 - Mar 2020
      Product manager gastro

      • Strategy design, launch strategy, internal and external communication to succeed in the launch, analysis and monitoring of the launch of Amitiza, achieving position as one of the main CIC products in Mexico, achieving 10% of MS before the first Release year in the IBS market and 38% in the CIC Market. • Strategic launch in the main states, increasing the prescriptions of physicians. • Launch of an on-line EMC to increase awareness disease in Chronic Idiopathic Constipation with PCP´s, "Hablemos de estreñiminto"• Development of an APP to help patients to manage their disease. "Siempre en Libertad"• Implementation of a new emotional strategy focused on the patient, highlighting adherence to the treatment and the benefits of the product, in order to slow down the fall of the product, achieving a growth of 2% in 2019.• Design of an internal loving campaign to change the mind of the sales force. Show less

    • Amgen

      Mar 2020 - now

      • Inclusion in IMSS, launch and development plan to increase awareness and knowledge of PCSK9 inhibitors, changing the mindset to use new therapies, Strategy design, launch strategy in IMSS, internal and external communication to succeed in the inclusion, analysis and mapping of the inclusion, preparation of the PSP, innovative online education awareness due to COVID momentum, and inclusion of detection campaigns to benefit more patients under control, growing doble digit. • Strategic mapping and contact to the new segment, with a huge challenge drive the prescription of a new product in a new institution. • Guide sales team, with mentoring activities and talent management identification to impulse people development.• Guide to execute a strategic POA (Plan of action) identification per territory with strong analysis and knowledge of market. • Launch of different Digital tools to increase awareness disease: Web page www.amgenone.com with the inclusion of cardiovascular area, 3 different Digital events to increase awareness in different segments.• Redesign of the PSP to include Private and Government benefits, also including a digital communication to increase adherence and knowledge about their disease. • Growth of double digit in 2020, 2021 and 2022 in the private market. • Change of the visual aid segmented by type of HCP, targeting the messages to the barriers that HCP has. • Inclusion of an omnichannel marketing strategy to the product to increase awareness and knowledge of the product per segment and in different channels. • Maintain of the leadership in the private market with a double-digit growth and a MS of 77% vs 70% 2020 and 100% in 2021 and 2022. • Strong partnership with principal cardiovascular societies planning different Strategies, Diplomado en Dislipidemia with ANCAM with more that 500 Cardiologist included. Show less

      • Business Unit Leader

        Nov 2023 - now
      • Sr. Product Manager Biotech en Amgen

        Mar 2020 - Nov 2023
  • Licenses & Certifications

  • Volunteer Experience

    • Voluntaria

      Issued by Centro Nacional Modelo de Atención, Investigación y Capacitación Gerontológico Arturo Mundet on Jan 2009
      Centro Nacional Modelo de Atención, Investigación y Capacitación Gerontológico Arturo MundetAssociated with Yosdi Arcos
    • Voluntaria

      Issued by Hogares Providencia Padre Chinchachoma on Jan 2008
      Hogares Providencia Padre ChinchachomaAssociated with Yosdi Arcos
    • Voluntaria

      Issued by Independiente on Jan 2017
      IndependienteAssociated with Yosdi Arcos